A Longitudinal Study of Effectiveness of Early Intervention for Preterm Infants

Premature Birth Clinical Trial

Official title:

A Longitudinal Study of Effectiveness of Early Intervention for Preterm Infants

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00946244
• Other study ID #: 200812114R
• Status: Completed
• Phase: N/A
• First received: July 22, 2009
• Last updated: February 21, 2017
• Start date: August 2009
• Est. completion date: August 2012

Study information

• Verified date: November 2009
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main purpose of this study is to extend the investigators' previous research to longitudinally examine the effectiveness of three early intervention programs: usual care program, clinic-based intervention program and home-based intervention program for very low birth weight preterm children at 3 and 4 years of age. Normal weight full-term children will also be included to serve as the reference group. Effectiveness assessments will include child, parenting, and transactions measures. Child outcome measures will include health status, growth, neurodevelopment and behavior; parenting outcome measures will include parental stress, competence, efficacy and family support; transactions outcome measure will include parent-child interaction procedures.

Description:

Accumulating data on early intervention for preterm infants illustrated short-term benefits on enhancing child development and decreasing parental stress, particularly for those of heavier birth weights. However, rare studies had designed early intervention program for small preterm infants and longitudinally examined the effectiveness in various outcome domains. Our research team recently conducted a clinical randomization trial on the effectiveness of three early intervention programs: usual care program (UCP), clinic-based intervention program (CBIP) and home-based intervention program (HBIP) on very low birth weight (VLBW, birth weight <1,500 g) preterm infants from the neonatal period to two years corrected age (CA). The latter two were comprehensive, intensive intervention programs that combined child- and parent-focused services beginning in hospitalization and ending at one year CA as delivered at clinic and home respectively. This three-year research project has extended our previous work to longitudinally examine the effectiveness of the three intervention programs in 180 VLBW preterm infants at 3 and 4 years of age. Sixty full-term infants will also be included to serve as the reference group. Outcome measures will include child (i.e., health, growth, neurodevelopment and behavior), parenting (i.e., parental stress, competency, efficacy and family support) and mother-child transactions (i.e., free-play and frustrating episode). The longitudinal data on the effectiveness of these early intervention programs for VLBW preterm infants will provide important information to help early intervention professionals and public policy makers to develop effective intervention for preterm children at risk for developmental problems.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 183
• Est. completion date: August 2012
• Est. primary completion date: August 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 3 Years to 4 Years

Eligibility

Inclusion Criteria:

• Body weight below 1501 gm

• Gestational age under 37 weeks

• Admission to the study hospitals within the first 7 days of life

• Singleton or the first child of twin or multiple births

• Physiologically stable at PCA 36 weeks as determined by attending physician

• Hospital discharge prior to PCA 44 weeks

Exclusion Criteria:

• Seizure

• Hydrocephalus

• Ventriculoperitoneal shunt

• Meningitis, periventricular leukomalacia

• Grade III to IV intraventricular hemorrhage

• Stage IV retinopathy of prematurity)

• Necrotizing enterocolitis with colostomy

• Severe cardiopulmonary disease requiring daily oxygen use at hospital discharge

Related Conditions & MeSH terms

• Premature Birth

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Child's development (health, growth, neurodevelopment and behavior)		3 and 4 years of age
Secondary	Parenting function (parent stress, competency, efficacy and family support)		3 and 4 years of age
Secondary	Parent-child transactions		3 and 4 years of age